Interestingly, both RRMS and CIS cases showed a decreased frequency of CD8low CD56+ CD3− CD4− cells which have a natural killer (NK) profile, adding to the hypothesis that NK regulatory properties may also be reduced in MS [113]. Here, CD4 is linked to in situ carcinoma.